Literature DB >> 28668480

A new challenge in forensic toxicology exemplified by a case of murder under the influence of a synthetic cannabinoid - AM-2201.

Sebastian Rojek1, Małgorzata Kłys2, Martyna Maciów-Głąb2, Karol Kula2.   

Abstract

Among new psychoactive substances (NPS) available on the narcotic market, a significant number consists of synthetic cannabinoids commonly known as smokable herbal "spice" and "K2", and which are legally treated as a legal alternative to marijuana. The dearth of information on the pharmacology of these intoxicants as they are introduced into the market has created the urgent need among healthcare providers for case studies on the substances belonging to this group, both in terms of the consequences of using such intoxicants, and in methods of detection. The subject of the present report is a multi-parameter analysis of a criminal case of an 18-year-old male who was charged with murder of his female relative and attempted murder of two other victims by stabbing. The defendant pleaded guilty, but he claimed that he had been acting without volition, because he was under the influence of the synthetic cannabinoid AM-2201, which had been purchased from a dealer as a 10g package labelled "Mr Green - No bad trip". Analytical methods including gas chromatography - electron ionization - quadrupole ion trap mass spectrometry (GC-EI-QIT/MS) and liquid chromatography, electrospray ionization, tandem mass spectrometry (LC-ESI-MS-MS) were developed to determine the presence of AM-2201 in the Mr Green - No Bad Trip, and in the blood of the perpetrator, respectively. Toxicological findings are discussed in the context of psychoactive and adverse physical effects resulting from the presence of AM-2201 in the human body; the observations were also analyzed in conjunction with data from the literature.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  AM-2201; New psychoactive substances (NPS); Synthetic cannabinoids

Mesh:

Substances:

Year:  2017        PMID: 28668480     DOI: 10.1016/j.legalmed.2017.06.004

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  3 in total

Review 1.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

2.  Review of the many faces of synthetic cannabinoid toxicities.

Authors:  Azita Alipour; Puja Baldev Patel; Zaheera Shabbir; Stephen Gabrielson
Journal:  Ment Health Clin       Date:  2019-03-01

3.  Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB).

Authors:  Priyanka Parajuli; Manjari Rani Regmi; Odalys Estefania Lara-Garcia; Ismael Abu Limon; Alan Deckard
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.